S&P 500   4,583.03 (+0.33%)
DOW   36,111.23 (+0.45%)
QQQ   388.44 (-0.10%)
AAPL   190.94 (+0.52%)
MSFT   372.16 (-1.78%)
META   322.89 (-1.30%)
GOOGL   130.99 (-1.16%)
AMZN   146.59 (+0.34%)
TSLA   237.16 (-1.22%)
NVDA   468.88 (+0.25%)
NIO   7.15 (-1.65%)
BABA   73.04 (-2.46%)
AMD   120.51 (-0.54%)
T   16.64 (+0.42%)
F   10.46 (+1.95%)
MU   76.23 (+0.14%)
CGC   0.58 (+3.75%)
GE   123.04 (+1.02%)
DIS   91.86 (-0.90%)
AMC   6.81 (+2.41%)
PFE   29.21 (-4.14%)
PYPL   58.60 (+1.72%)
XOM   103.78 (+1.01%)
S&P 500   4,583.03 (+0.33%)
DOW   36,111.23 (+0.45%)
QQQ   388.44 (-0.10%)
AAPL   190.94 (+0.52%)
MSFT   372.16 (-1.78%)
META   322.89 (-1.30%)
GOOGL   130.99 (-1.16%)
AMZN   146.59 (+0.34%)
TSLA   237.16 (-1.22%)
NVDA   468.88 (+0.25%)
NIO   7.15 (-1.65%)
BABA   73.04 (-2.46%)
AMD   120.51 (-0.54%)
T   16.64 (+0.42%)
F   10.46 (+1.95%)
MU   76.23 (+0.14%)
CGC   0.58 (+3.75%)
GE   123.04 (+1.02%)
DIS   91.86 (-0.90%)
AMC   6.81 (+2.41%)
PFE   29.21 (-4.14%)
PYPL   58.60 (+1.72%)
XOM   103.78 (+1.01%)
S&P 500   4,583.03 (+0.33%)
DOW   36,111.23 (+0.45%)
QQQ   388.44 (-0.10%)
AAPL   190.94 (+0.52%)
MSFT   372.16 (-1.78%)
META   322.89 (-1.30%)
GOOGL   130.99 (-1.16%)
AMZN   146.59 (+0.34%)
TSLA   237.16 (-1.22%)
NVDA   468.88 (+0.25%)
NIO   7.15 (-1.65%)
BABA   73.04 (-2.46%)
AMD   120.51 (-0.54%)
T   16.64 (+0.42%)
F   10.46 (+1.95%)
MU   76.23 (+0.14%)
CGC   0.58 (+3.75%)
GE   123.04 (+1.02%)
DIS   91.86 (-0.90%)
AMC   6.81 (+2.41%)
PFE   29.21 (-4.14%)
PYPL   58.60 (+1.72%)
XOM   103.78 (+1.01%)
S&P 500   4,583.03 (+0.33%)
DOW   36,111.23 (+0.45%)
QQQ   388.44 (-0.10%)
AAPL   190.94 (+0.52%)
MSFT   372.16 (-1.78%)
META   322.89 (-1.30%)
GOOGL   130.99 (-1.16%)
AMZN   146.59 (+0.34%)
TSLA   237.16 (-1.22%)
NVDA   468.88 (+0.25%)
NIO   7.15 (-1.65%)
BABA   73.04 (-2.46%)
AMD   120.51 (-0.54%)
T   16.64 (+0.42%)
F   10.46 (+1.95%)
MU   76.23 (+0.14%)
CGC   0.58 (+3.75%)
GE   123.04 (+1.02%)
DIS   91.86 (-0.90%)
AMC   6.81 (+2.41%)
PFE   29.21 (-4.14%)
PYPL   58.60 (+1.72%)
XOM   103.78 (+1.01%)

NovaBay Pharmaceuticals (NBY) Earnings Date, Estimates & Call Transcripts

$0.29
-0.01 (-2.73%)
(As of 11:06 AM ET)
Compare
Today's Range
$0.29
▼
$0.32
50-Day Range
$0.29
▼
$0.49
52-Week Range
$0.28
▼
$2.66
Volume
69,172 shs
Average Volume
497,410 shs
Market Capitalization
$1.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsSocial Media

Earnings Summary

Latest
Earnings Date
Nov. 9Estimated
Actual EPS
(Nov. 9)
-$0.37 Missed By -$0.37
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

NBY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NBY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NovaBay Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate:($2.54) EPS
Next Year EPS Consensus Estimate: ($0.55) EPS

NBY Earnings Date and Information

NovaBay Pharmaceuticals last released its earnings results on November 9th, 2023. The reported ($0.37) earnings per share (EPS) for the quarter. The company earned $3.27 million during the quarter. NovaBay Pharmaceuticals has generated ($6.82) earnings per share over the last year (($6.82) diluted earnings per share). Earnings for NovaBay Pharmaceuticals are expected to grow in the coming year, from ($2.54) to ($0.55) per share.

NovaBay Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/9/2023Q3 2023-($0.37)($0.37)($0.37)-$3.27 million
8/10/2023Q2 2023-($1.27)($1.27)($1.27)-$4.61 million
5/11/2023Q1 2023-($0.85)($0.85)($0.85)-$3.12 million
3/30/2023Q4 2022-($4.33)($4.33)($4.33)-$3.64 million
11/14/2022Q3 2022-($3.50)($3.50)($3.50)-$3.83 million
8/11/2022Q2 2022-($1.40)($1.40)($1.40)-$3.05 million
3/29/2022Q4 2021-($0.70)($0.70)($0.70)-$2.64 million
11/11/2021Q3 2021-($1.75)($1.75)($1.75)-$1.84 million
8/12/2021Q2 2021-($1.40)($1.40)($1.40)-$2.13 million
5/6/2021Q1 2021-($1.40)($1.40)($1.40)-$1.81 million
3/25/2021Q4 2020-($1.40)($1.40)($1.40)-$1.89 million












NovaBay Pharmaceuticals Earnings - Frequently Asked Questions

When did NovaBay Pharmaceuticals announce their last quarterly earnings?

NovaBay Pharmaceuticals (NYSE:NBY) last announced its quarterly earning data on Thursday, November 9, 2023. Learn more on NBY's earnings history.

How much revenue does NovaBay Pharmaceuticals generate each year?

NovaBay Pharmaceuticals (NYSE:NBY) has a recorded annual revenue of $14.40 million.

How much profit does NovaBay Pharmaceuticals generate each year?

NovaBay Pharmaceuticals (NYSE:NBY) has a recorded net income of -$10.61 million. NBY has generated -$6.82 earnings per share over the last four quarters.

What is NovaBay Pharmaceuticals's EPS forecast for next year?

NovaBay Pharmaceuticals's earnings are expected to grow from ($2.54) per share to ($0.55) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:NBY) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -